1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine hydrochloride, 97%, 10g

5-Chloromethyl-3-methyl-isoxazole-4-carboxylic acid ethyl ester, 95.0%, 5g

Methyl 8-bromo-1-naphthoate, 97%, 5g

4-Bromomethyl-2-(4-tert-butyl-phenyl)-5-methyl-thiazole, 95.0%, 1g

methyl 2-benzyl-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate, 95%, 100mg

3-(DIFLUOROMETHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE, 95.0%, 250mg

(1H-Pyrrol-3-yl)methanol, 95%, 250mg

4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, 98%, 100mg

Sample bags ROTILABO® with labelling area, 40 mm, Height, 60 mm, 100 Piece(s)

2,2,2-Trifluoro-1-(1,2,4,5-tetrahydro-7-nitro-1,5-methano-3H-3-benzazepin-3-yl)ethanone, 97%, 500mg

5-Bromo-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, 95+%, 1g

3-Fluoro-4-(2-fluorophenoxy)aniline, 98%, 25g

2',3'-Difluoroacetophenone, 98.0%, 5g